The Xience Short DAPT Study, sponsored by Abbott Vascular, leads a long list of clinical trials that have been announced, started, or completed in the last month.
The Xience Short DAPT study is a 2,000-patient prospective, multicenter, single-arm study of dual-antiplatelet therapy in subjects at high risk for bleeding who are undergoing coronary intervention with any of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?